Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial

IMPORTANCE: In the Insulin Resistance Intervention After Stroke (IRIS) randomized clinical trial, pioglitazone, an insulin-sensitizing agent, reduced the risk for recurrent stroke or myocardial infarction (MI) among patients with insulin resistance. However, insulin resistance is not commonly measur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: Spence, J. David, Viscoli, Catherine M., Inzucchi, Silvio E., Dearborn-Tomazos, Jennifer, Ford, Gary A., Gorman, Mark, Furie, Karen L., Lovejoy, Anne M., Young, Lawrence H., Kernan, Walter N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6515584/
https://ncbi.nlm.nih.gov/pubmed/30734043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.0079
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados